Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Mammographic screening: evidence from randomised controlled trials
H J de Koning
European Journal of Radiology
|
February 16, 2000
Breast cancer screening; cost-effective in practice?
H J De Koning
BJU International
|
February 27, 2004
MISCAN: estimating lead-time and over-detection by simulation
G Draisma, H J De Koning
American Journal of Obstetrics and Gynecology
|
December 1, 1995
Randomized comparison of the effects of endocervical and vaginal prostaglandin E2 gel in women with various degrees of cervical ripeness. Dutch Collaborative Prostaglandin Trialists' Group
M J Keirse, H J de Koning Gans
Journal of Medical Screening
|
May 29, 2015
Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods
H J de Koning, E A M Heijnsdijk
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
August 14, 2012
Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions
F W Schultz, R Boer, H J de Koning
Journal of Medical Screening
|
May 22, 2004
Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
S J Otto, F H Schröder, H J de Koning
BJU International
|
February 27, 2004
Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
M L Essink-Bot, I J Korfage, H J De Koning
Cancer
|
October 20, 1999
A longer breast carcinoma screening interval for women age older than 65 years?
R Boer, H J de Koning, P J van der Maas
Journal of Medical Screening
|
August 13, 1999
Psychosocial predictors of first attendance for organised mammography screening
A R Aro, H J de Koning, P Absetz, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Mammographic screening: evidence from randomised controlled trials
H J de Koning
European Journal of Radiology
|
February 16, 2000
Breast cancer screening; cost-effective in practice?
H J De Koning
BJU International
|
February 27, 2004
MISCAN: estimating lead-time and over-detection by simulation
G Draisma, H J De Koning
American Journal of Obstetrics and Gynecology
|
December 1, 1995
Randomized comparison of the effects of endocervical and vaginal prostaglandin E2 gel in women with various degrees of cervical ripeness. Dutch Collaborative Prostaglandin Trialists' Group
M J Keirse, H J de Koning Gans
Journal of Medical Screening
|
May 29, 2015
Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods
H J de Koning, E A M Heijnsdijk
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
August 14, 2012
Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions
F W Schultz, R Boer, H J de Koning
Journal of Medical Screening
|
May 22, 2004
Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
S J Otto, F H Schröder, H J de Koning
BJU International
|
February 27, 2004
Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
M L Essink-Bot, I J Korfage, H J De Koning
Cancer
|
October 20, 1999
A longer breast carcinoma screening interval for women age older than 65 years?
R Boer, H J de Koning, P J van der Maas
Journal of Medical Screening
|
August 13, 1999
Psychosocial predictors of first attendance for organised mammography screening
A R Aro, H J de Koning, P Absetz, et al.
Page
of 12